Moreover, a recent study suggested that Didymin treatment significantly attenuated the MPO activity and neutrophil infiltration and converted pro-inflammatory M1-like to the anti-inflammatory M2-like macrophage phenotype, thereby alleviating the clinical symptoms of colitis (25). Here, MPO is linked to colitis.